152 related articles for article (PubMed ID: 15384941)
1. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases.
Azzouz M; Mazarakis N
Curr Gene Ther; 2004 Sep; 4(3):277-86. PubMed ID: 15384941
[TBL] [Abstract][Full Text] [Related]
2. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vectors for treating and modeling human CNS disorders.
Azzouz M; Kingsman SM; Mazarakis ND
J Gene Med; 2004 Sep; 6(9):951-62. PubMed ID: 15352068
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy for ALS: progress and prospects.
Azzouz M
Biochim Biophys Acta; 2006; 1762(11-12):1122-7. PubMed ID: 16806843
[TBL] [Abstract][Full Text] [Related]
5. Transduction patterns of pseudotyped lentiviral vectors in the nervous system.
Wong LF; Azzouz M; Walmsley LE; Askham Z; Wilkes FJ; Mitrophanous KA; Kingsman SM; Mazarakis ND
Mol Ther; 2004 Jan; 9(1):101-11. PubMed ID: 14741783
[TBL] [Abstract][Full Text] [Related]
6. Development and applications of non-HIV-based lentiviral vectors in neurological disorders.
Valori CF; Ning K; Wyles M; Azzouz M
Curr Gene Ther; 2008 Dec; 8(6):406-18. PubMed ID: 19075624
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.
Federici T; Kutner R; Zhang XY; Kuroda H; Tordo N; Boulis NM; Reiser J
Genet Vaccines Ther; 2009 Jan; 7():1. PubMed ID: 19144125
[TBL] [Abstract][Full Text] [Related]
8. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
9. EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.
Balaggan KS; Binley K; Esapa M; MacLaren RE; Iqball S; Duran Y; Pearson RA; Kan O; Barker SE; Smith AJ; Bainbridge JW; Naylor S; Ali RR
Gene Ther; 2006 Aug; 13(15):1153-65. PubMed ID: 16572190
[TBL] [Abstract][Full Text] [Related]
10. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
11. Gene-based treatment of motor neuron diseases.
Federici T; Boulis NM
Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND
Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.
Haase G; Kennel P; Pettmann B; Vigne E; Akli S; Revah F; Schmalbruch H; Kahn A
Nat Med; 1997 Apr; 3(4):429-36. PubMed ID: 9095177
[TBL] [Abstract][Full Text] [Related]
15. Stable gene transfer to the nervous system using a non-primate lentiviral vector.
Mitrophanous K; Yoon S; Rohll J; Patil D; Wilkes F; Kim V; Kingsman S; Kingsman A; Mazarakis N
Gene Ther; 1999 Nov; 6(11):1808-18. PubMed ID: 10602376
[TBL] [Abstract][Full Text] [Related]
16. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.
Alisky JM; Davidson BL
Hum Gene Ther; 2000 Nov; 11(17):2315-29. PubMed ID: 11096437
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.
O'Rourke JP; Newbound GC; Kohn DB; Olsen JC; Bunnell BA
J Virol; 2002 Feb; 76(3):1510-5. PubMed ID: 11773424
[TBL] [Abstract][Full Text] [Related]
19. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]